Human Rhinovirus Molecular Epidemiology and Genotyping in Iranian Military Trainees with Acute Respiratory Symptoms

AUTHORS

Fahimeh Safarnezhad Tameshkel ORCID 1 , 2 , Ali Salimi Jeda ORCID 3 , Ahmad Tavakoli 4 , Mohammad Hadi Karbalaie Niya ORCID 2 , 3 , * , Morteza Izadi ORCID 5 , Farhad Zamani ORCID 2 , Hossein Keyvani 2 , 3

1 Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

2 Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran

3 Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

4 Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

5 Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

How to Cite: Safarnezhad Tameshkel F , Salimi Jeda A , Tavakoli A , Karbalaie Niya M H, Izadi M , et al. Human Rhinovirus Molecular Epidemiology and Genotyping in Iranian Military Trainees with Acute Respiratory Symptoms, J Arch Mil Med. 2020 ; 8(4):e111224. doi: 10.5812/jamm.111224.

ARTICLE INFORMATION

Journal of Archives in Military Medicine: 8 (4); e111224
Published Online: April 28, 2021
Article Type: Research Article
Received: December 20, 2020
Accepted: April 18, 2021
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Background: Human rhinovirus (HRV) is still the most prevalent viral infection in humans and a significant cause of acute respiratory tract infections (ARTIs) in many communities, including military personnel undergoing basic training.

Objectives: In this research, we assessed the molecular epidemiology, genotyping, and phylogenetic classification of HRVs in Iranian military trainees with respiratory infections (RI).

Methods: For HRV identification and genotyping, respiratory specimens were obtained, and RT-PCR was conducted for genotyping and phylogenetic analysis of HRV utilizing primers for the 5-UTR region.

Results: Among 400 Iranian military trainees (average age of 21 ± 4 years, the range of 18 - 57 years) with respiratory infections, HRV was detected in 29 patients (7%) using RT-PCR. The direct sequencing of PCR products from 10 specimens showed that the incidence of type A (n = 5, 50%) was higher than that of type B (n = 4, 40%) and type C (n = 1, 10%). There were no significant associations between HRV and respiratory and clinical symptoms, blood group, and indoor or outdoor conditions (P-value > 0.05).

Conclusions: This research was the first to record HRV as a significant cause of respiratory problems among military trainees in Iran, with a frequency of 7%. The most prevalent genotype was HRV-A, which may be applicable in epidemiological and clinical studies, as well as vaccination plans.

1. Background

Respiratory disorders impose a tremendous burden on global public health. Acute lower respiratory tract infections have been among the leading three reasons for mortality and morbidity among adults and children for decades, indicating the astounding global burden of lung infections (1).

Military trainees are at elevated risk of acute respiratory infections (ARI), disrupting their preparation and contribution to military readiness and causing tremendous losses. Immunity wanes under conditions such as high physical and psychological tension and in crowded places like military training camps (2). Respiratory disorders have been described as the main causes of morbidities and the shortening of training duration among military personnel (3).

Investigations have also shown that key viral etiologies, including adenoviruses, influenza A and B viruses, Epstein-Barr virus, coronaviruses, and rhinoviruses, are mainly associated with ARIs. Human rhinovirus (HRV) is the causative agent of one-half to two-third of common cold cases (4, 7). Infants may be infected 8 to 12 times per year, while adults usually contract the virus 2 to 3 times annually, and multiple peaks may occur during the year (4).

Human rhinoviruses, first characterized in vitro in 1956 (5), belong to the Enterovirus genus of the picornaviridae family and are classified into three species, namely HRV-A, HRV-B, and HRV-C. These viruses impose high medical costs and are responsible for about three out of four cases with upper respiratory tract infections (URTIs) or cold symptoms (nasal obstruction, coughing, rhinorrhea, and sore throat). They are also major causes of the aggravation of chronic obstructive pulmonary infections and asthma. Human rhinoviruses are mainly transmitted by aerosolization. Thus, HRVs inflict remarkable epidemiological, clinical, and economic impacts (e.g., missing a job, an education, or medical treatment) (6). To date, the number of strains/serotypes of HRVs have been reported to be more than 160 (7).

Traditionally, HRVs are characterized by URTIs, otitis media, and sinusitis. Using PCR-based assays, HRV has been identified as an LRTI pathogen, especially in asthmatic patients (children and adults) and immunocompromised hosts. There are currently no licensed antiviral agents for HRV, and therapy is predominantly supportive. Vaccine development efforts have been hampered by the presence of more than 100 HRV serotypes with an extremely high heterogeneity at antigenic sites. The management of HRV infections remains predominantly supportive via alleviating symptoms by over-the-counter remedies (8).

Human rhinoviruses invade the respiratory system’s epithelial cells, especially the nasal passage and nasopharynx, and do not seem to spread to the submucosa, lower respiratory parts, or digestive mucosa since HRVs optimally propagate between 33 and 35°C, and relatively higher temperatures at lower airways restrict HRV proliferation. Certain HRV serotypes, such as HRV-C, uniformly propagate between 33 and 37°C. After RSVs, HRVs are the most common causes of wheezing in babies. Also, HRVs are repeatedly identified in upper airway sputum and bronchial biopsies (9, 10), as well as the lower airway biopsies of children with chronic coughing (11, 12).

2. Objectives

Here, we investigated the prevalence of the serotypes and genotypes of HRVs in military trainees in their mid-20s, who had just been recruited to Iran’s Military Training Camp. Individuals with ARIs were prospectively examined for HRV molecular and epidemiological features throughout the primary military training course.

3. Methods

3.1. Subjects and Sample Collection

From January 2015 to February 2016, many new reservists experienced an intensive three-month essential preparation course, throughout which they remained together in a single-wide barracks within a large dormant quarter. Four hundred respiratory specimens were obtained from the soldiers of the military barracks, who attended the medical center of the preparation camp with the clinical symptoms and signs of an influenza‐like illness (ILI) or URR [such as an oral temperature of ≥ 37.5°C (i.e., febrile respiratory illness (FRI)], sore throat, cough, and runny nose) or fresh ARI (a body temperature of < 37.5°C). Following the medical examination, specimens including sputum, throat swabs, and nasal wash were obtained. Those with a history of severe respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD), the patients refusing to take antiviral treatments, and military personnel were excluded from the study. Specimens were shipped to the laboratory in virus transport media and stored at -70°C until use.

3.2. RNA Extraction and cDNA Synthesis

Viral RNA was isolated from 200 μL of each sample employing a viral RNA extraction kit (Roche Applied Science, Mannheim, Germany) as directed by the manufacturer. RNase-free-DNase I was used to extract DNA. Using a Nanodrop 2000 spectrophotometer (Thermo Science, the USA), the quantity and purity of nucleic acids were measured. After that, 0.1 ng to 5 μg of the extracted RNA was used to produce cDNA. Then 8.2 μL of the isolated viral RNA was explicitly used in cDNA synthesis using a first-strand cDNA synthesis package (Thermo Scientific RevertAid) and random hexamers as instructed by the manufacturer. Consequently, 2 μL of the synthesized cDNA was applied for conducting PCR.

The online Primer 3 platform was employed to design primers. Two oligonucleotides [P-Forward (5'-CAAGCACTTCTGTTTCCC) and P-reverse (5'-CACGGACACCCAAAGTAGT)] were applied to amplify a 397-bp fragment in the 5-UTR region of HRV genome. The specificity of the primers used in this study was confirmed before conducting PCR.

The PCR mixture (25 μL) contained 2.5 U pfu polymerase (Fermentas Life Sciences, Vilnius, Lithuania), 2.5 μL of 0.2 μM primers, 10 X buffer, and 200 μM dNTP. Afterwards, PCR started with an initial denaturation phase at 95°C for 2 min, followed by 30 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 2 min. For the final extension, reaction tubes remained at 72°C for 5 min. Amplicons were run on 2% agarose gel prepared by TAE buffer and visualized by ethidium bromide staining. A 100-bp DNA ladder [marker XIV (Roche Applied Research, Mannheim, Germany)] was utilized as a molecular weight marker.

3.3. Nucleotide Sequencing and Phylogenetic Analysis

The 5-UTR amplicons of HRV genome were sequenced, and the findings were compared to the Query Sequence via Clustal X Software (version 1.83) and evaluated using the BioEdit and Treecon programs for drawing a phylogenetic tree. This software has a Kimura Nj system with a bootstrap value of 1000 Rep. A phylogenetic tree with a bootstrap of > 70% is considered to be accurate.

4. Results

A total of 400 military trainees showing the clinical symptoms of RIs were enrolled in this research. All the subjects were male with an average age of 21 ± 4 years. The most common blood groups were A (141/400, 32.2%) and O (139/400, 34.7%), and the least frequent was the AB blood group (34/400, 8%). Regarding clinical symptoms, most patients complained of sore throat (n = 233, 58.25%) followed by cold (n = 41, 10.25%), cough (n = 33, 8.25%), and rhinorrhea (n = 10, 2.5%) (Table 1). Regarding residence in the camp, 51% (205/400) went outside every day, and 49% (195/400) remained in the camp for a long period.

Table 1. Clinical Symptoms of Participants (n = 400)
SymptomsHRV PCRTotal
Negative (%)Positive (%)
Fever > 38.5°C1 (0.2)01 (0.2)
Cough31 (7.7)2 (6.8)33 (8.2)
Rhinorrhea9 (2.2)1 (3.4)10 (2.5)
Shortness of breath4 (1)04 (1)
Sore throat217 (54.2)16 (55.1)233 (58.2)
Sore throat/cough6 (1.5)06 (1.5)
Sputum/cough3 (0.7)03 (0.7)
Sore throat/cold36 (9)2 (6.8)38 (9.5)
Sore throat/headache3 (0.7)1 (3.4)4 (1)
Sore throat/rhinorrhea3 (0.7)03 (0.7)
Sore throat/cough20 (5)2 (6.8)22 (5.5)
Cold36 (9)5 (17.2)41 (10.2)
Sore throat/fever2 (0.5)02 (0.5)
Total371 (93)29 (7)400 (100)

The amplification of the unique HRV 5'-UTR region produced a sharp 397-bp band (Figure 1). Totally, 29 patients (7%) aged 22 ± 5 years (95% CI: 20 - 24) had HRV infection (P = 0.0001) based on RT-PCR findings. Of these, 19 (59%) had a sore throat, five had flu, three had sore throat and cold, and two had a cough (P = 0.0001). Regarding ABO blood groups, 46% (15/29) had O blood group followed by A (7/29, 21%), AB (5/29, 15%), and B (2/29, 6%) (P = 0.0001). Of these, 71% (23/29) were travelers and settled out of the camp at night, and 18% (6/29) remained in the camp for a long period (P = 0,081).

Figure 1. HRV RT-PCR. Products were visualized by agarose gel electrophoresis. Lanes 53, 64, 188, 190, and 193 show 397-bp bands and belong to HRV positive cases. A 100-bp DNA marker (Roche Applied Science, Mannheim, Germany) was used to designate the band’s size (lane L). C-, negative control; and C+, positive control.

Ten out of the 29 positive samples were sent for nucleotide sequencing and phylogenetic analysis. The existence of HRV was confirmed in the samples tested based on nucleotide sequencing. The phylogenetic tree revealed 5 (50%) HRV-A, 4 (40%) HRV-B, and 1 (10%) HRV-C. Of patients with HRV-A infection, 80% had a sore throat, 10% had a sore throat with the cough, and the remaining had cold symptoms. In HRV-B positive patients, only a sore throat was found. Regarding residency inside or outside the military base, 51.2% went outside the camp, and 48.8% had a permanent presence in the base. Of those with HRV-A, most (n = 7; 3.6%) were inside the camp, and the remaining (n = 3; 1.5%) were outside the camp. There was also a positive HRV-B specimen among those who migrated outside the camp. Of patients with HRV-A infections, three (30%) had < 19 years, 4 (40%) had 20 to 21 years old (n = 4), one (10%) belonged to a 43 years old man, and one (10%) was over 51 years old. Patients with HRV-B infections were 20 to 21 years old.

The phylogenetic examination of the sequenced RT-PCR products exhibited that strains No. 36 and 19 were compatible with the strains isolated from the Philippines and the USA, respectively. The majority of the isolated strains were comparable to the sequences obtained from the USA (Figure 2).

Figure 2. The phylogenetic tree drawn using the neighbor-joining method for some HRV-positive samples. The strains identified in this study and out-group sequences were analyzed against reference sequences (red circles). Phylogenetic trees were constructed using the neighbor-joining method (Kimura’s two-parameter) with 1,000 bootstrap values. The numbers in each branch indicate how close strains were to each other.

5. Discussion

Screening HRVs, particularly in severe cases of RTIs, may be accompanied with the detection of new emerging viral strains, endangering global health security. The precise detection of pathogens in the clinical setting is critical for early interventions and avoiding disease propagation (13, 14). Pneumonia is the major cause of morbidity and mortality in children worldwide, with nearly 120 million cases diagnosed each year (15). Respiratory viruses are responsible for 14 to 80% of childhood community-acquired pneumonia in infants, with HRV being the most commonly identified pathogen. Various HRV strains (i.e., A, B, and C) have been reported in association with mild RTIs and asthma exacerbation (16).

Militaries are particularly and theoretically at higher risks of RTIs than other social classes. In a survey conducted by the Acute Respiratory Diseases Commission in the US recruitment camps, the prevalence of RTIs among recruited trainees was greater than that of other trained military groups (17). Experiments in military applicants also reported elevated rates of RTIs. Among military trainees, HRV infections were related to RTIs with more difficulties in breathing and a lower rate of pneumonia (18). In young and healthy individuals, these pathogens typically cause moderate and self-limiting infections (19). Studying the clinical and/or epidemiological features of HRV-infected trainees indicates the emergence of the "common cold" syndrome (50%) and other signs such as headache and sore throat and a surge in the incidence of this infection among trainees (20 - 70%) with LRT signs such as dyspnea and pneumonia (20).

Tan et al., in their investigation, reported that the prevalence of HRV infection was between 3 and 4% in USAFSAM Military Treatment facilities (MTFs) (18). The routine monitoring of febrile respiratory infection (FRI) cases by Singaporean military personnel from May 2009 to October 2012 revealed an incidence of 7.4% for rhinoviruses (18). Radin et al., in their study on the epidemiology of RTIs among three US communities (citizens along the US-Mexico frontier, recipients of the Department of Defense (DoD), and military recruits) between October 2011 and March 2013, identified rhinoviruses in 16% of samples. In addition, the disease was more severe in outpatient FRI cases than in inpatients (SARI) (21). Another study conducted by Lau et al. on the incidence of respiratory viral infections in Singapore military members in 2016 exhibited that rhinoviruses were the most prevalent pathogens detected in respiratory specimens (nearly 47% of samples) (3). Levy et al. investigated the incidence of upper RTIs among novice trainees in military camps in Thailand and identified rhinoviruses in 22 (28.57%) out of 77 nasal/throat swab specimens obtained during the basic training period (17). Wang et al. assessed throat swabs from military recruits with FRIs by microarray and showed that out of 97 specimens, 78 were HRVs (73 cases of HRV-A and five cases of HRV-B). Also, 46 of 73 confirmed HRV-A specimens were positive for HAdV-4 (22). Another study by Yun et al. on acute RTIs among the military trainees vaccinated against adenoviruses in Philadelphia from June 2008 to August 2013 revealed a dramatic reduction in the incidence of the infection compared with before vaccine usage, all viral infections identified in 68.4% (1266/1850) of which 17.8% (335/1880) were rhinovirus infection (23).

Furthermore, Kopra et al. searched for HRV species in the sputum specimens of military trainees with respiratory infections and exhibited that among 386 sputum specimens, 146 (37.8%) were positive for HRVs based on RT-PCR, including Of 146 HRV positive strains, 55 were positive in typing assay, and then, 29 had a reliable sequence for interpretation among 29 strains, 18 were HRV-A, 5 were HRV-B, and 6 were different genetic types (16).

In this research, 400 patients were recruited, of whom 29 were diagnosed with HRVs. Of the ten samples sequenced, five, four, and one rendered HRV-A, HRV-B, and HRV-C, respectively, showing similarities in the phylogenetic analysis. The sequences submitted from the Philippines and the US strains in the GeneBank database indicate a high heterogeneity in HRV-A strains. These viruses were not linked with any neurological symptom or mortality in the studied population. There were no significant differences in the clinical and demographic features of the patients infected with various HRV strains. Many studies have indicated that HRV-A is a minimally pathogenic virus. Disease severity was not significantly different between patients with HRV-A and HRV-C. The prevalence of the O blood group was high among trainees with HRV infection, suggesting a role for this blood group in susceptibility to this virus.

From the limitations of this study are relatively low sample size (especially the positive cases) and not discriminating ARI from FRI cases. In fact, any ARI case may eventually develop FRI. This limitation might have contributed to the underestimation of FRI events. This study primarily included young adult males in a semi-closed military environment. Thus, the results recorded here would not be relevant to the general adult population (24).

5.1. Conclusion

This investigation aimed to describe the prevalence, clinical features, and molecular epidemiology of HRVs in Iranian military trainees with RTIs. Our findings showed that most RTIs were due to HRVs, particularly HRV-A. Nevertheless, most of our samples had been collected during the first six months of the year, so it is recommended to perform comparative and more comprehensive research in the second half of the year, during which these diseases are more prevalent. Studies in the military barracks of other regions of Iran will help to determine the actual prevalence of HRVs and their possible sources in the country. Despite advances in molecular diagnostic methods, allowing the rapid detection of HRV infections, antiviral agents, and vaccination remain significant prerequisites for the management of these infections.

Footnotes

References

  • 1.

    Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11(3):404-6. doi: 10.1513/AnnalsATS.201311-405PS. [PubMed: 24673696].

  • 2.

    O'Shea MK, Ryan MA, Hawksworth AW, Alsip BJ, Gray GC. Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment. Clin Infect Dis. 2005;41(3):311-7. doi: 10.1086/431591. [PubMed: 16007526].

  • 3.

    Lau YF, Koh WV, Kan C, Dua PA, Lim AE, Liaw CJ, et al. Epidemiologic analysis of respiratory viral infections among Singapore military servicemen in 2016. BMC Infect Dis. 2018;18(1):123. doi: 10.1186/s12879-018-3040-x. [PubMed: 29529993]. [PubMed Central: PMC5848554].

  • 4.

    Casanova V, Sousa FH, Stevens C, Barlow PG. Antiviral therapeutic approaches for human rhinovirus infections. Future Virol. 2018;13(7):505-18. doi: 10.2217/fvl-2018-0016. [PubMed: 30245735]. [PubMed Central: PMC6136076].

  • 5.

    Pelon W, Mogabgab WJ, Phillips IA, Pierce WE. A cytopathogenic agent isolated from naval recruits with mild respiratory illnesses. Proc Soc Exp Biol Med. 1957;94(2):262-7. doi: 10.3181/00379727-94-22915. [PubMed: 13408229].

  • 6.

    Williams GR, Kubajewska I, Glanville N, Johnston SL, McLean GR. The potential for a protective vaccine for rhinovirus infections. Expert Rev Vaccines. 2016;15(5):569-71. doi: 10.1586/14760584.2016.1142375. [PubMed: 26766290].

  • 7.

    McIntyre CL, Knowles NJ, Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol. 2013;94(Pt 8):1791-806. doi: 10.1099/vir.0.053686-0. [PubMed: 23677786]. [PubMed Central: PMC3749525].

  • 8.

    Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev. 2013;26(1):135-62. doi: 10.1128/CMR.00077-12. [PubMed: 23297263]. [PubMed Central: PMC3553670].

  • 9.

    Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997;155(3):1159-61. doi: 10.1164/ajrccm.155.3.9117003. [PubMed: 9117003].

  • 10.

    Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR, Weisshaar E, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med. 2005;171(6):645-51. doi: 10.1164/rccm.200407-970OC. [PubMed: 15591468].

  • 11.

    Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181(6):1875-84. doi: 10.1086/315513. [PubMed: 10837165].

  • 12.

    Malmstrom K, Pitkaranta A, Carpen O, Pelkonen A, Malmberg LP, Turpeinen M, et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol. 2006;118(3):591-6. doi: 10.1016/j.jaci.2006.04.032. [PubMed: 16950276].

  • 13.

    Al-Tawfiq JA, Zumla A, Gautret P, Gray GC, Hui DS, Al-Rabeeah AA, et al. Surveillance for emerging respiratory viruses. Lancet Infect Dis. 2014;14(10):992-1000. doi: 10.1016/S1473-3099(14)70840-0. [PubMed: 25189347]. [PubMed Central: PMC7106459].

  • 14.

    Ren L, Yang D, Ren X, Li M, Mu X, Wang Q, et al. Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21. Sci Rep. 2017;7:41601. doi: 10.1038/srep41601. [PubMed: 28128353]. [PubMed Central: PMC5269714].

  • 15.

    Lau SK, Yip CC, Tsoi HW, Lee RA, So LY, Lau YL, et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol. 2007;45(11):3655-64. doi: 10.1128/JCM.01254-07. [PubMed: 17804649]. [PubMed Central: PMC2168475].

  • 16.

    Savolainen-Kopra C, Blomqvist S, Kaijalainen S, Jounio U, Juvonen R, Peitso A, et al. All known human rhinovirus species are present in sputum specimens of military recruits during respiratory infection. Viruses. 2009;1(3):1178-89. doi: 10.3390/v1031178. [PubMed: 21994588]. [PubMed Central: PMC3185535].

  • 17.

    Levy JW, Bhoomiboonchoo P, Simasathien S, Salje H, Huang A, Rangsin R, et al. Elevated transmission of upper respiratory illness among new recruits in military barracks in Thailand. Influenza Other Respir Viruses. 2015;9(6):308-14. doi: 10.1111/irv.12345. [PubMed: 26271648]. [PubMed Central: PMC4605412].

  • 18.

    Tan XQ, Zhao X, Lee VJ, Loh JP, Tan BH, Koh WH, et al. Respiratory viral pathogens among Singapore military servicemen 2009-2012: Epidemiology and clinical characteristics. BMC Infect Dis. 2014;14:204. doi: 10.1186/1471-2334-14-204. [PubMed: 24735158]. [PubMed Central: PMC4006965].

  • 19.

    Turner RB, Lee WM. Rhinovirus. In: Richman DD, Whitley RJ, Hayden FG, editors. Clinical virology. 3rd ed. Maryland, United States: American Society for Microbiology; 2009. p. 1063-82.

  • 20.

    Sanchez JL, Cooper MJ, Myers CA, Cummings JF, Vest KG, Russell KL, et al. Respiratory infections in the U.S. Military: Recent experience and control. Clin Microbiol Rev. 2015;28(3):743-800. doi: 10.1128/CMR.00039-14. [PubMed: 26085551]. [PubMed Central: PMC4475643].

  • 21.

    Radin JM, Hawksworth AW, Kammerer PE, Balansay M, Raman R, Lindsay SP, et al. Epidemiology of pathogen-specific respiratory infections among three US populations. PLoS One. 2014;9(12). e114871. doi: 10.1371/journal.pone.0114871. [PubMed: 25549089]. [PubMed Central: PMC4280218].

  • 22.

    Wang Z, Malanoski AP, Lin B, Long NC, Leski TA, Blaney KM, et al. Broad spectrum respiratory pathogen analysis of throat swabs from military recruits reveals interference between rhinoviruses and adenoviruses. Microb Ecol. 2010;59(4):623-34. doi: 10.1007/s00248-010-9636-3. [PubMed: 20217405].

  • 23.

    Yun HC, Young AN, Caballero MY, Lott L, Cropper TL, Murray CK. Changes in clinical presentation and epidemiology of respiratory pathogens associated with acute respiratory illness in military trainees after reintroduction of adenovirus vaccine. Open Forum Infect Dis. 2015;2(3):ofv120. doi: 10.1093/ofid/ofv120. [PubMed: 26380351]. [PubMed Central: PMC4569648].

  • 24.

    Pang J, Jin J, Loh JP, Tan BH, Koh WH, Ng SH, et al. Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: A case-control study. BMC Infect Dis. 2015;15:288. doi: 10.1186/s12879-015-1024-7. [PubMed: 26208494]. [PubMed Central: PMC4514976].

  • Copyright © 2021, Journal of Archives in Military Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: